Research Paper Volume 12, Issue 20 pp 20835—20861
SMARCD3 is a potential prognostic marker and therapeutic target in CAFs
Figure 1. GO and KEGG pathway enrichment network analysis of TME related genes. (A) Venn diagram analysis of DEGs based on immune or stromal scores. (B–E) GO (biological process, molecular function and cellular component) and KEGG pathway enrichment network analysis of 372 commonly upregulated genes in TME. (F) Protein-protein interaction network of 372 TME related genes.